Aromasin may prevent recurrence and breast cancer

Aromasin pills
Photo Karl Stephan

Aromasin (exemestane) can prevent new cases of breast cancer, as well as recurrence in postmenopausal women. you'll be glad to know that exemestane soon might be available in generic form, such as the patent expired on April 1 that would make for a low-cost drug that reduces the number of newly diagnosed breast cancers.

This news is the result of a study done by NCIC clinical trials group at Queen's University in Ontario, Canada. results of the study were presented at this year's meeting of the American Society of Clinical Oncology in Chicago. The New England Journal of Medicine published a study, which lasted 5 years and included more than 4500 women living in North America, Spain, and France. women in this study were already of menopause and were identified as being at high risk for breast cancer.

This is not the first time that a hormone therapy has been regarded as chemoprevention power of breast cancer for tamoxifen was widely prescribed for many pre-and postmenopausal women after treatment for cancer. estrogen-sensitive breast prevents the return of breast cancer by blocking estrogen receptors, but it doesn't stop of estrogen production. the disadvantage of tamoxifen, and the reason that many patients do not take it to the full five years which is the default schemethe side effects of tamoxifen causes menopause-... as hot flashes, night sweats and increases the risk of endometrial cancer, cataracts, and stroke.

Aromasin has softer side effects than tamoxifen and estrogen tamoxifen blocks differently and Aromasin prevents production.product estrogen that Aromasin is an aromatase inhibitor that is often given to patients with postmenopausal breast cancer who have completed treatment for cancer of the breast estrogen-sensitive nor drugs would benefit patients who have tumors of breast estrogen receptor negativeas Triple negative Breast Cancer (TNBC).

Don't rush out and ask your doctor to prescribe exemestane such as breast cancer prevention studies just yet. that more must be done on its benefits and risks, as well as their effectiveness in preventing the development of breast tumors in women at high risk. But if research continues, this drug may prevent many preventive mastectomies in young and older women who already had genetic testing and found to have a strong family history and genetic predisposition to breast cancer for those women who do not mind an early hot flashes to avoid a breast tumorthe side effects of exemestane does not seem so bad.

View the original article here